Winton Group LTD Genocea Biosciences, Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.91 - $2.67 $22,826 - $31,909	-11,951 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$1.81 - $5.53 $30,234 - $92,373	-16,704 Reduced 58.29%	11,951 $27,000
Q2 2020 Aug 05, 2020	BUY	$1.66 - $3.06 $18,454 - $34,018	11,117 Added 63.39%	28,655 $66,000
Q1 2020 May 11, 2020	BUY	$1.26 - $2.73 $22,097 - $47,878	17,538 New	17,538 $30,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.